1. Biochemical processing of E-cadherin under cellular stress.
- Author
-
Keller SH and Nigam SK
- Subjects
- Animals, Anti-Bacterial Agents pharmacology, Antimycin A pharmacology, Breast Neoplasms, Caspase 3, Caspase Inhibitors, Caspases genetics, Cell Fractionation, Cell Line, Cysteine Proteinase Inhibitors metabolism, Cytochrome c Group metabolism, Cytoskeletal Proteins metabolism, Deoxyglucose metabolism, Dogs, Enzyme Activation, Epithelial Cells cytology, Epithelial Cells drug effects, Female, Humans, In Situ Nick-End Labeling, Oligopeptides metabolism, Trans-Activators metabolism, beta Catenin, Cadherins metabolism, Caspases metabolism, Epithelial Cells metabolism, Peptide Fragments metabolism
- Abstract
The proteolytic cleavage pathways of E-cadherin endogenously expressed in MDCK (Madin-Darby canine kidney) cells were characterized in cells treated with antimycin A and deoxyglucose to examine transmembrane protein processing under cellular stress. E-cadherin is a type I transmembrane protein which operates as the cell adhesion molecule component of the adherens junction, a complex of proteins involved in epithelial tissue development and integrity. We now demonstrate that treatment of MDCK cells with antimycin A and deoxyglucose activates caspase mediated pathways that cleave E-cadherin. E-cadherin is cleaved into two major fragments, with the sizes predicted by the location of a caspase-3 cleavage consensus sequence. Cleavage of E-cadherin and deposition of the C-terminal fragment into the cytoplasm are inhibited by the caspase inhibitor DEVD-CHO. Thus, a major mechanism for E-cadherin cleavage and dissolution of the adherens junction under antimycin/deoxyglucose treatment is caspase mediated, initiated by activation of an apoptosis pathway.
- Published
- 2003
- Full Text
- View/download PDF